Cargando…

Pharmaceutical care for patients with breast and ovarian cancer

PURPOSE: Individualized patient care may help reduce the incidence of adverse drug events in systemic cancer therapy. This study was conducted to explore the feasibility and potential of additional pharmaceutical care for breast and ovarian cancer patients. METHODS: The study was designed as a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liekweg, Andrea, Westfeld, Martina, Braun, Michael, Zivanovic, Oliver, Schink, Tania, Kuhn, Walther, Jaehde, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461211/ https://www.ncbi.nlm.nih.gov/pubmed/22298194 http://dx.doi.org/10.1007/s00520-012-1385-z

Ejemplares similares

Minimising treatment-associated risks in systemic cancer therapy
por: Jaehde, Ulrich, et al.
Publicado: (2007)

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care
por: Simons, Sven, et al.
Publicado: (2010)

Non-invasive proteomics—thinking about personalized breast cancer screening and treatment
por: Debald, Manuel, et al.
Publicado: (2010)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients
por: Mallmann, Michael R., et al.
Publicado: (2010)

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial
por: Lenssen, R., et al.
Publicado: (2018)

In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
por: Pölcher, Martin, et al.
Publicado: (2010)

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
por: Kalayda, Ganna V, et al.
Publicado: (2008)

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries
por: Cimino, Ernesto, et al.
Publicado: (2014)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting – Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)
por: Rose, Olaf, et al.
Publicado: (2016)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
por: Penn, Courtney A., et al.
Publicado: (2022)

Pharmacist-led medication reviews for geriatric residents in German long-term care facilities
por: Bitter, Kerstin, et al.
Publicado: (2019)

Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic
por: Schumacher, Sofie, et al.
Publicado: (2023)

The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data
por: Czwikla, Jonas, et al.
Publicado: (2017)

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
por: Jiménez-Sánchez, Alejandro, et al.
Publicado: (2017)

Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
por: Vanguri, Rami, et al.
Publicado: (2022)

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research
por: Kienle, Gunver S, et al.
Publicado: (2009)

Pharmaceutical Care in Sports
por: Bomfim, José Henrique Gialongo Gonçales
Publicado: (2020)

Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities
por: Schink, Michael, et al.
Publicado: (2017)

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study
por: Thöne, Kathrin, et al.
Publicado: (2017)

Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer
por: Kloft, C, et al.
Publicado: (2003)

What is 'pharmaceutical care' in 2013?
por: van Mil, J. W. Foppe, et al.
Publicado: (2013)

Pharmaceutical care in smoking cessation
por: Marín Armero, Alicia, et al.
Publicado: (2015)

Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
por: Ortland, Imke, et al.
Publicado: (2022)

Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study
por: Krolop, Linda, et al.
Publicado: (2013)

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
por: Barber, Emma L., et al.
Publicado: (2013)

Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study
por: En‐nasery ‐ de Heer, Selma, et al.
Publicado: (2022)

Integrated care in ovarian cancer “IgV Ovar”: results of a German pilot for higher quality in treatment of ovarian cancer
por: Keyver-Paik, M.-D., et al.
Publicado: (2015)

‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention
por: Debald, Manuel, et al.
Publicado: (2013)

Early postoperative substitution procedure of the antioxidant ascorbic acid (AA) in postoperative intensive care unit (ICU) patients
por: Ruemelin, A, et al.
Publicado: (2004)

Pharmaceutical care in Brazil’s primary health care
por: Araújo, Patricia Sodré, et al.
Publicado: (2017)

Correction: Qamar et al. Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics 2023, 15, 1813
por: Qamar, Safi Ur Rehman, et al.
Publicado: (2023)

Der Europäische MSM Internet Survey als Grundlage für die Präventionsarbeit in Deutschland für Männer, die Sex mit Männern haben
por: Marcus, Ulrich, et al.
Publicado: (2021)

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer
por: Vitarello, John, et al.
Publicado: (2021)

Familial Breast and Ovarian Cancer
por: Spence, R A J
Publicado: (2003)

The genetics of breast and ovarian cancer.
por: Ford, D., et al.
Publicado: (1995)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

HRness in Breast and Ovarian Cancers
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c2g4gm9abk76q16t8761ov5ghu